540788
ASPIRA
Start SIP
Invest Now
Start SIP in ASPIRA
Performance
- Low
- ₹63
- High
- ₹64
- 52 Week Low
- ₹50
- 52 Week High
- ₹107
- Open Price₹64
- Previous Close₹63
- Volume334
Investment Returns
- Over 1 Month -2.48%
- Over 3 Month + 3.14%
- Over 6 Month + 12.3%
- Over 1 Year + 2.94%
Smart Investing Starts Here Start SIP with Aspira Pathlab & Diagnostics for Steady Growth!
Aspira Pathlab & Diagnostics Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 19
- PEG Ratio
- 0
- Market Cap Cr
- 65
- P/B Ratio
- 4.5
- Average True Range
- 3.93
- EPS
- -
- Dividend Yield
- 0
- MACD Signal
- 0.31
- RSI
- 44.41
- MFI
- 16.79
Aspira Pathlab & Diagnostics Financials
Aspira Pathlab & Diagnostics Technicals
EMA & SMA
Current Price
₹63.00
+
0.45
(0.72%)
- Bearish Moving Average 14
- Bullish Moving Average 2
- 20 Day
- ₹65.28
- 50 Day
- ₹64.84
- 100 Day
- ₹64.05
- 200 Day
- ₹62.55
Resistance and Support
63.49
- R3 65.43
- R2 64.95
- R1 63.97
- S1 62.51
- S2 62.03
- S3 61.05
Aspira Pathlab & Diagnostics Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2025-11-12 | Quarterly Results | |
| 2025-08-12 | Quarterly Results | |
| 2025-05-16 | Audited Results | |
| 2025-02-07 | Quarterly Results | |
| 2024-11-12 | Quarterly Results |
Aspira Pathlab & Diagnostics F&O
About Aspira Pathlab & Diagnostics
- NSE Symbol
- ASPIRA
- BSE Symbol
- 540788
- Managing Director & CEO
- Dr. Pankaj J Shah
- ISIN
- INE500C01017
Similar Stocks to Aspira Pathlab & Diagnostics
Aspira Pathlab & Diagnostics FAQs
Aspira Pathlab & Diagnostics share price is ₹63 As on 25 December, 2025 | 11:13
The Market Cap of Aspira Pathlab & Diagnostics is ₹64.8 Cr As on 25 December, 2025 | 11:13
The P/E ratio of Aspira Pathlab & Diagnostics is 19 As on 25 December, 2025 | 11:13
The PB ratio of Aspira Pathlab & Diagnostics is 4.5 As on 25 December, 2025 | 11:13
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.